Navigation Links
Discovery of key protein's shape could lead to improved bacterial pneumonia vaccine

Scientists at St. Jude Children's Research Hospital have discovered that the shape of a protein on the surface of pneumonia bacteria helps these germs invade the human bloodstream. This finding, published Dec. 16 online by the EMBO Journal, could help scientists develop a vaccine that is significantly more effective at protecting children against the disease. The St. Jude researchers determined the shape of a large, paddle-like molecule that Streptococcus pneumoniae bacteria use to latch onto cells lining the throat and lungs. The protein, called CbpA, binds to a molecule on the cell called pIgR, which takes antibodies from the bloodstream on one side of the cell and transports them to the other side. There it releases the antibody at the lining of the throat and lungs. If a pneumococcus bacterium is hovering on the lining of the respiratory tract, this germ binds to pIgR and pushes this antibody shuttle back through the cell to the bloodstream. Once at the other side of the cell, the pneumococcus breaks free of pIgR and enters the blood, where it can multiply and infect the body.

S. pneumoniae is the only bacterium known to use CbpA to invade human cells by binding to pIgR, according to Richard W. Kriwacki, Ph.D., associate member of St. Jude Structural Biology. Kriwacki is senior author of the EMBO Journal report. “The fact that we now know the structure of this important protein means we can begin to develop a vaccine that is more effective in children than those that are currently available,?Kriwacki said. Elaine Tuomanen, M.D., chair of Infectious Diseases and director of the Children’s Infection Defense Center at St. Jude, is co-author of the EMBO Journal paper. “Using CbpA as the key part of a new vaccine against S. pneumoniae would solve a problem that now hinders our ability to protect children from this infection,?Tuomanen said. Current pneumonia vaccines designed to protect adults against more than two dozen strains of S. pneumoniae do not work in
'"/>

Source:St. Jude Children's Research Hospital


Page: 1 2 3

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
3. Discovery Could Lead To Novel Approaches In HIV Treatment
4. Discovery Promises Simpler Therapy for Sickle Cell Disease
5. Discovery may lead to better Candidiasis drug
6. Protein Discovery Could Unlock The Secret To Better TB Treatment
7. Discovery clarifies role of peptide in biological clock
8. Eliminate Data Analysis Bottlenecks in Drug Discovery
9. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
10. Discovery could be key to bioterrorism defense
11. Discovery of an American salamander where it shouldnt be: Korea
Post Your Comments:
(Date:6/11/2015)... Va. , June 11, 2015 ... technology, announced today that its IdentityX Mobile Authentication ... (Fast IDentity Online) Alliance is an industry consortium ... open standards for simpler, stronger authentication.  In order ... must pass a rigorous series of tests that ...
(Date:6/9/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... will be providing demonstrations of its iMedNet ... Information Association (DIA) Annual Meeting in Washington ... include previews of many exciting new enhancements that will ... 2015 Feature 1 Release. MedNet ...
(Date:6/8/2015)... , June 8, 2015  Trovagene, Inc. (NASDAQ: TROV ... clinical data featuring its Precision Cancer Monitoring SM platform ... Liquid Biopsies conference in San Diego, CA ... Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy ... June 13-16. "We continue to advance our ...
Breaking Biology News(10 mins):Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4
... HEIDELBERG, GERMANY, 20 OCTOBER 2011 EMBO today ... from 14 countries by awarding them life-long EMBO membership. ... commitment to research excellence and the exceptional achievements made ... the ranks of 1,500 of the best researchers in ...
... sativa has been exploited by humanity. Hemp seed oil ... its fibre is used in the production of fabrics. ... used medicinally for over 2700 years. The changes to the ... cannabis evolution, but one that has now been solved, thanks ...
... Wildfire, insect outbreaks and hurricanes destroy huge amounts ... carbon dioxide entering the atmosphere, but scientists are now ... their climate impact. Researchers conclude in a new ... of energy reflected back into space, is important in ...
Cached Biology News:46 outstanding life scientists elected to EMBO membership 2The cannabis genome: How hemp got high 2'Albedo effect' in forest disturbances can cause added warming, bonus cooling 2'Albedo effect' in forest disturbances can cause added warming, bonus cooling 3
(Date:7/7/2015)... ... July 07, 2015 , ... ... community in the biometrical area. What began as a conference for European Statistical ... for various functions in the biometrical area. Statistical Programmers, Data Managers and Biostatisticians ...
(Date:7/7/2015)... ... July 07, 2015 , ... Currently deployed ... was developed to solve many of the complex logistical and data management ... involve multiple clinical sites and/or remote data coordination centers. , CentrePoint drastically ...
(Date:7/6/2015)... CARDIFF, UK (PRWEB) , ... July 06, 2015 ... ... and other medical fields holds potential to reveal how blood flows in the ... stroke-induced damage to the brain. , A new article published in the journal ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... Medicine, recently hosted their 2015 bi-annual Pain Management Medical Advisory Board meeting in ... Proove Biosciences’ executive Research and Development team to discuss new clinical practice and ...
Breaking Biology Technology:PhUSE Delighted to Welcome Member Number 5.000 2ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 2ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 3Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 3Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 3
... TORONTO, Aug. 27 Drug Royalty LP 2 ... Pharmaceuticals, Inc.,s (ENZN) worldwide,royalty interest in PEG-INTRON for ... in 2012 should certain royalty recognition levels be ... of,Hepatitis C and is marketed worldwide by Schering-Plough ...
... Notice is hereby,given that the 2007 Annual General Meeting ... (NASDQ:ROSG) (the "Company"), an,Israeli company, will be held at ... Tower, 47th floor, Tel Aviv, Israel on Monday, September ... purposes: 1. To approve the appointment of Kost, ...
... SAN CARLOS, Calif., Aug. 27 NeurogesX, Inc.,(Nasdaq: NGSX ... announced today that it is scheduled to present,at the 2007 ... Anthony DiTonno, President and Chief Executive Officer,and Stephen Ghiglieri, Chief ... Date: Thursday, September 6, 2007 ...
Cached Biology Technology:Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN) 2Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007 2NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 2NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 3
... pLivSelect is a direct ... recombinant identification. Recombinant selection ... survival, eliminating the need ... This quick and inexpensive ...
... has been designed and created in order ... friendly genotyping analysis tool. We incorporated the ... into the software. Their main requirements were ... low acquisition cost. GeneMarker can perform ...
... through columns is a well-known separation technique ... applications are in DNA/RNA extraction in microbiology, ... purification in chemical or analytical laboratories. ... Genesis series instruments for smaller scales. The ...
... 3D structure visualization, phylogenetic tree building, sequence ... single application. Retrieve ... and filter them in real-time Organize ... searching, filtering and sorting Provides up-to-date ...
Biology Products: